Suppression of DPYD expression in RKO Cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Dihydropyrimidine dehydrogenase (DPD) is one of the factors that determine the efficacy and toxicity of 5-fluorouracil. Variations in DPD activity may result from alterations at the transcriptional level of the DPYD gene. Heterogeneity in DPYD expression has been reported, but the molecular mechanisms responsible for this remain unclear. We investigated methylation of the DPYD promoter as a mechanism for transcriptional regulation of DPYD in the RKO colorectal cancer cell line. We demonstrate that the active transcription machinery for DPYD is present in RKO cells, but promoter binding of Sp1, a transactivator of DPYD, was inhibited, which on subsequent examination was shown to be associated with dense promoter methylation. Treatment with 5-aza-2'-deoxycytidine alone or the combination of 5-aza-2'-deoxycytidine and trichostatin A induced demethylation of the promoter and markedly increased the DPYD mRNA level in RKO cells but not in unmethylated WiDr cells. Furthermore, in vitro methylation of the DPYD promoter decreased promoter activity. These data suggest an important role for methylation in DPYD suppression. The transcriptional suppression of DPYD by methylation may be responsible for the increased 5-fluorouracil sensitivity observed in some patients. This may also provide insight into the mechanism underlying the downregulation of DPYD in some colorectal cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Preclinical studies have shown that methylation of the DPYD gene promoter, which encodes DPD protein, can inhibit DPYD transcription [98].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [98]
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,646
Cameron, E. E., Bachman, K. E., Myöhänen, S., Herman, J. G., & Baylin, S. B. (1999) · Nature Genetics · doi:10.1038/5047 · Cited by 1,857
Johnson, M. R., Wang, K., Smith, J. B., Heslin, M. J., & Diasio, R. B. (2000) · Analytical Biochemistry · doi:10.1006/abio.1999.4461 · Cited by 336
Self-citationCpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene.
Ohtani‐Fujita, N., Fujita, T., Aoike, A., Osifchin, N. E., Robbins, P. D., & Sakai, T. (1993) · PubMed · Cited by 311
DNA methyltransferase inhibitors—state of the art
Goffin, J., & Eisenhauer, E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf314 · Cited by 283
Genotype and phenotype in patients with dihydropyrimidine dehydrogenase deficiency
Van Kuilenburg, A. B. P., Vreken, P., Abeling, N. G. G. M., Bakker, H. D., Meinsma, R., Van Lenthe, H., De Abreu, R. A., Smeitink, J. A. M., Kayserili, H., Apak, M. Y., et al. (1999) · Human Genetics · doi:10.1007/pl00008711 · Cited by 282
Enzymes of uracil catabolism in normal and neoplastic human tissues.
Naguib, F. N. M., el Kouni, M. H., & Cha, S. (1985) · PubMed · Cited by 277
Methylation of Adjacent CpG Sites Affects Sp1/Sp3 Binding and Activity in the p21Cip1 Promoter
Zhu, W.-G., Srinivasan, K., Dai, Z., Duan, W., Druhan, L. J., Ding, H., Yee, L., Villalona-Calero, M. A., Plass, C., & Otterson, G. A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4056-4065.2003 · Cited by 257
The Cell-specific Expression of Endothelial Nitric-oxide Synthase
Chan, Y., Fish, J. E., D'Abreo, C., Lin, S., Robb, G. B., Teichert, A.-M., Karantzoulis-Fegaras, F., Keightley, A., Steer, B. M., & Marsden, P. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405063200 · Cited by 243
Momparler, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206774 · Cited by 242
Research works printed but not linked: 7
- Diasio R.B., 1999, Clin. Cancer Res., 5, 2672
- Fukushima M., 2003, Int. J. Mol. Med., 12, 839
- Johnston S.J., 1999, Clin. Cancer Res., 5, 2566
- Naguib F.N., 1985, Cancer Res., 45, 5405
- Ohtani-Fujita N., 1993, Oncogene, 8, 1063
- Shin T.H., 1992, Mol. Cell. Biol., 12, 3998
- Takabayashi A., 2000, Int. J. Oncol., 17, 889
Cited by
Blondy, S., David, V., Verdier, M., Mathonnet, M., Perraud, A., & Christou, N. (2020) · Cancer Science · doi:10.1111/cas.14532 · Cited by 507
Gastric cancer: Classification, histology and application of molecular pathology.
Hu, B., Elhajj, N., Sittler, S. Y., Lammert, N., Barnes, R., & Meloni‐Ehrig, A. (2012) · PubMed · doi:10.3978/j.issn.2078-6891.2012.021 · Cited by 490
The role of Sp1 and Sp3 in normal and cancer cell biology
Li, L., & Davie, J. R. (2010) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/j.aanat.2010.07.010 · Cited by 318
Self-citationDrug Resistance in Colorectal Cancer: From Mechanism to Clinic
Wang, Q., Shen, X., Chen, G., & Du, J. (2022) · Cancers · doi:10.3390/cancers14122928 · Cited by 160
Metadata
- Authors
- Zhang, X., Soong, R., Wang, K., Li, L., Davie, J. R., Guarcello, V., & Diasio, R. B.
- Affiliations
- Mayo Clinic (US)
- Venue
- Biochemistry and Cell Biology
- Publisher
- Canadian Science Publishing
- Published
- 2007-06
- Volume
- 85
- Issue
- 3
- Pages
- 337-346
- ISSN
- 0829-8211 (ISSN-L)
- 1208-6002
- OpenAlex
- W1985632884
- Cited by
- 21
- References
- 38
- Citations by year
- 2024: 1 · 2022: 3 · 2021: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2013: 1 · 2012: 3
- FWCI
- 1.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.nrcresearchpress.com/page/about/CorporateTextAndDataMining (tdm)
- Locations
- Biochemistry and Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- Funders
- National Cancer Institute (CA-62164, R01CA062164)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Keywords
- dihydropyrimidine dehydrogenase, DNA methylation, epigenetic silencing, Sp1, 5-fluorouracil sensitivity, colorectal cancer, RKO cells, decitabine, trichostatin A, transcriptional regulation, promoter activity
- MeSH terms
- Decitabine, Azacitidine, Base Sequence, DNA, Neoplasm, Humans, Hydroxamic Acids, Promoter Regions, Genetic, RNA, Messenger, RNA, Neoplasm, Suppression, Genetic, Colorectal Neoplasms, Gene Expression Regulation, Enzymologic, Sp1 Transcription Factor, DNA Primers, DNA Methylation, Dihydrouracil Dehydrogenase (NADP), Epigenesis, Genetic, Cell Line, Tumor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Suppression of DPYD expression in RKO Cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. https://app.cochat.ai/papers/10.1139/o07-009
- The paper
- Zhang, X., Soong, R., Wang, K., Li, L., Davie, J. R., Guarcello, V., & Diasio, R. B. (2007). Suppression of DPYD expression in RKO Cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression. Biochemistry and Cell Biology. https://doi.org/10.1139/o07-009
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.